These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 16033837

  • 1. Cyclooxygenase-2 expression in postmastectomy chest wall relapse.
    Kim JH, Bossuyt V, Ponn T, Lannin D, Haffty BG.
    Clin Cancer Res; 2005 Jul 15; 11(14):5199-205. PubMed ID: 16033837
    [Abstract] [Full Text] [Related]

  • 2. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.
    Haffty BG, Hauser A, Choi DH, Parisot N, Rimm D, King B, Carter D.
    Cancer; 2004 Jan 15; 100(2):252-63. PubMed ID: 14716758
    [Abstract] [Full Text] [Related]

  • 3. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
    Haffty BG, Yang Q, Moran MS, Tan AR, Reiss M.
    Int J Radiat Oncol Biol Phys; 2008 Jul 15; 71(4):1006-13. PubMed ID: 18262731
    [Abstract] [Full Text] [Related]

  • 4. Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy.
    Cho EI, Kowalski DP, Sasaki CT, Haffty BG.
    Laryngoscope; 2004 Nov 15; 114(11):2001-8. PubMed ID: 15510031
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 6. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E, Haffty BG.
    Cancer J Sci Am; 2000 Mar 20; 6(1):28-33. PubMed ID: 10696736
    [Abstract] [Full Text] [Related]

  • 7. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression.
    Parikh RR, Yang Q, Higgins SA, Haffty BG.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):35-42. PubMed ID: 17855007
    [Abstract] [Full Text] [Related]

  • 8. Chest wall relapse after mastectomy for ductal carcinoma in situ: a report of 10 cases with a review of the literature.
    Kim JH, Tavassoli F, Haffty BG.
    Cancer J; 2006 Jan 01; 12(2):92-101. PubMed ID: 16630397
    [Abstract] [Full Text] [Related]

  • 9. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA.
    J Am Coll Surg; 2005 Jun 01; 200(6):912-21. PubMed ID: 15922205
    [Abstract] [Full Text] [Related]

  • 10. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.
    Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D.
    J Clin Oncol; 2006 Dec 20; 24(36):5652-7. PubMed ID: 17116942
    [Abstract] [Full Text] [Related]

  • 11. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):797-804. PubMed ID: 14967436
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 13. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E.
    Cancer Invest; 2008 Aug 12; 26(7):671-9. PubMed ID: 18608215
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, Cronin M, Walker M, Watson D, Shak S, Hortobagyi GN.
    Clin Cancer Res; 2005 May 01; 11(9):3315-9. PubMed ID: 15867229
    [Abstract] [Full Text] [Related]

  • 15. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
    Amornmarn R, Bui MM, Prempree TB, Masood S.
    Ann Clin Lab Sci; 2000 Jan 01; 30(1):33-40. PubMed ID: 10678581
    [Abstract] [Full Text] [Related]

  • 16. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Perrone G, Santini D, Vincenzi B, Zagami M, La Cesa A, Bianchi A, Altomare V, Primavera A, Battista C, Vetrani A, Tonini G, Rabitti C.
    Histopathology; 2005 May 01; 46(5):561-8. PubMed ID: 15842638
    [Abstract] [Full Text] [Related]

  • 17. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR, Susini T, Amunni G, Paglierani M, Taddei A, Marchionni M, Scarselli G, Taddei GL.
    Gynecol Oncol; 2005 Jan 01; 96(1):159-67. PubMed ID: 15589595
    [Abstract] [Full Text] [Related]

  • 18. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
    Kuo SH, Huang CS, Kuo WH, Cheng AL, Chang KJ, Chia-Hsien Cheng J.
    Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1456-64. PubMed ID: 18692329
    [Abstract] [Full Text] [Related]

  • 20. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 01; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.